NEXTCELL PHARMA

NextCell is a Swedish biopharmaceutical company headquartered in Huddinge, adjacent to the Karolinska University Hospital. NextCell operates in two business areas - Cellaviva and ProTrans - with the shared core being stem and stromal cells derived from the umbilical cord... NextCell was founded in 2014 by CEO Dr. Mathias Svahn, two current board members; Professor Edvard Smith and Hans-Peter Ekre, as well as Dr. Lena Degling Wilkingsson. The company was originally named Cellaviva AB. In 2016, a strategic decision was made to expand the operation and also conduct drug development and stromal cell research. At this point the company changed its name to NextCell Pharma AB.

Also known as: NextCell, NextCell Pharma AB, NextCell Pharma AB (publ)

Primary location: Sweden